Guardion Health Sciences, Inc. (GHSI): Price and Financial Metrics

Guardion Health Sciences, Inc. (GHSI): $9.25

0.15 (+1.65%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

C

Add GHSI to Watchlist
Sign Up

Industry: Consumer Goods

Industry

B

Ranked

#32 of 51

in industry

GHSI Price/Volume Stats

Current price $9.25 52-week high $10.75
Prev. close $9.10 52-week low $5.01
Day low $9.17 Volume 3,100
Day high $9.29 Avg. volume 138,409
50-day MA $8.45 Dividend yield N/A
200-day MA $7.24 Market Cap 11.88M

GHSI Stock Price Chart Interactive Chart >


Guardion Health Sciences, Inc. (GHSI) Company Bio


Guardion Health Sciences, Inc. provides health care services. It offers, Lumega-Z a medical food formulated to replenish and restore the macular protective pigment. The firm also develops medical devices that measures macular pigment density. The company was founded by Michael Favish in 2009 and is headquartered in San Diego, CA.


GHSI Latest News Stream


Event/Time News Detail
Loading, please wait...

GHSI Latest Social Stream


Loading social stream, please wait...

View Full GHSI Social Stream

Latest GHSI News From Around the Web

Below are the latest news stories about GUARDION HEALTH SCIENCES INC that investors may wish to consider to help them evaluate GHSI as an investment opportunity.

Guardion Health Sciences Announces Financial Results for the Three Months and Nine Months Ended September 30, 2023

Viactiv® Generated Net Revenues of Approximately $3.3 Million for the Three Months Ended September 30, 2023, an increase of 27% over the Three Months Ended September 30, 2022 HOUSTON, TEXAS, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition company that offers a portfolio of science-based, clinically-supported products designed to support the health needs of consumers, healthcare professionals and providers and the

Yahoo | November 13, 2023

Guardion Health Sciences Announces Financial Results for the Three Months and Six Months Ended June 30, 2023

Viactiv® Product Line Total Revenue Increased Approximately 6% for the Six Months Ended June 30, 2023, as Compared to the Six Months Ended June 30, 2022; Robust Growth in Amazon Sales Channel Demonstrates Positive Results of Company’s Focus on eCommerce InitiativesHOUSTON, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition company that offers a portfolio of science-based, clinically-supported products designed to su

Yahoo | August 14, 2023

Guardion Health Sciences Announces Appointment of Former Neutrogena and Coca-Cola Executive Jan Hall as President and Chief Executive Officer

Former President and Chief Executive Officer Bret Scholtes Resigning to Pursue Other Business OpportunitiesHOUSTON, May 30, 2023 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition company that offers a portfolio of science-based, clinically-supported products designed to support the health needs of consumers, healthcare professionals and providers and their patients, announced that Janet (“Jan”) Hall has been appointed as the Com

Yahoo | May 30, 2023

Guardion Health Sciences Announces Financial Results for the Quarter Ended March 31, 2023

Viactiv® Product Line Total Revenue Increased approximately 37% for the Quarter Ended March 31, 2023 as compared to the Quarter Ended March 31, 2022HOUSTON, May 15, 2023 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition company that offers a portfolio of science-based, clinically-supported products designed to support the health needs of consumers, healthcare professionals and providers and their patients, announced its financia

Yahoo | May 15, 2023

Guardion Health Sciences Announces Financial Results for the Year Ended December 31, 2022

Viactiv® Product Line Generated Net Revenues of approximately $10.6 Million or 96% of Net Revenues for the Year Ended December 31, 2022HOUSTON, April 17, 2023 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition company that offers a portfolio of science-based, clinically-supported products designed to support the health needs of consumers, healthcare professionals and providers and their patients, announced its financial results f

Yahoo | April 17, 2023

Read More 'GHSI' Stories Here

GHSI Price Returns

1-mo 15.91%
3-mo 9.14%
6-mo 58.64%
1-year 40.35%
3-year -87.41%
5-year -98.08%
YTD 73.22%
2023 -26.40%
2022 -77.58%
2021 -74.01%
2020 88.38%
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!